Summary

Specimen Collection Cards Market Growth & Trends

The global specimen collection cards market size is expected to reach USD 621.3 million by 2030, registering a CAGR of 5.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to register promising growth owing to the increasing emphasis on non-invasive procedures, favorable government policies for newborn screening, and increasing investments in research & development. Moreover, ease of use and cost-effectiveness of the products is also likely to have a positive impact on the market growth.

The market is experiencing significant growth due to the increasing focus on personalized medicine, genetic testing, health monitoring, and well-being initiatives. Personalized medicine aims to customize medical treatments based on individual genetic profiles, lifestyle factors, and other relevant information. Genetic testing plays a vital role in this approach by providing insights into an individual's genetic makeup, enabling personalized diagnostics, treatment selection, and disease prevention strategies. Specimen collection cards have become essential tools in genetic testing processes, offering a convenient and reliable method for collecting various biological samples, such as saliva, blood, and tissue.

Moreover, specimen collection cards contribute to health monitoring and well-being programs by enabling the collection of biomarkers & analytes that provide valuable information about an individual's health status and overall well-being. These cards are used in kits designed for monitoring hormone levels, detecting infectious diseases, and measuring key biomarkers related to chronic conditions like diabetes or cardiovascular diseases.

The ease of sample collection using specimen collection cards promotes regular monitoring, facilitating early detection of health issues and timely interventions, ultimately leading to improved health outcomes. The growing emphasis on personalized medicine, genetic testing, health monitoring, and well-being initiatives is driving the demand for specimen collection cards in the market. These cards provide a practical solution by offering a versatile and user-friendly platform for collecting various biological samples, empowering individuals to take control of their health. The integration of specimen collection cards into innovative genetic testing kits and health monitoring solutions further solidifies their role in supporting personalized medicine and enabling individuals to make well-informed decisions about their health & well-being.

Key players operating in the industry are focusing on raising funds to excel in their research and development activities along with other inorganic and organic strategies. For instance, in June 2022, OrisDX received funding for its innovation in saliva-based diagnostics for oral cancers. The company received funding of USD 1.76 million as an investment for progressing its research. Such developments are estimated to offer a favorable environment for the adoption of specimen collection cards during the forecast period.

Specimen Collection Cards Market Report Highlights

• The specimen collection cards industry is expected to witness considerable growth due to rising emphasis on personalized medicines and cost-efficiency.

• The blood sample segment held the largest share in 2024, owing to an extensive rate of newborn screening in developed as well as developing countries.

• In 2024, the cotton & cellulose-based segment dominated the material segment owing to its operational superiority over other materials. Furthermore, the improved capacity of cotton & cellulose-based material for sample storage and integrity also drives its growth.

• The Whatman 903 product segment dominated the market in 2024 owing to its adoption in various government initiatives and research studies. Moreover, the extensive geographical presence of the company is also playing a major role in dominating market share.

• The newborn screening segment dominated the application segment in 2024. The favorable regulatory environment for newborn screening in several countries is contributing to the segment growth.

• The offline segment dominated the market in 2024 owing to convenient access. The online segment is estimated to register the fastest CAGR due to technological advancements.

• The hospital and clinics end-use segment held the major market share in 2024 due to its substantial adoption.

• North America dominated the market in 2024 due to the presence of key players and rising support from the government.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type of specimen
1.2.2. Material
1.2.3. Product
1.2.4. Application
1.2.5. Distribution channel
1.2.6. End-use
1.2.7. Regional scope
1.2.8. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type of specimen outlook
2.2.2. Material outlook
2.2.3. Product outlook
2.2.4. Application outlook
2.2.5. Distribution channel outlook
2.2.6. End-use outlook
2.2.7. Regional outlook
2.3. Competitive Insights
Chapter 3. Specimen Collection Cards Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise of forensic to toxicology applications
3.2.1.2. Growing Focus on personalized medicine and genetic testing
3.2.1.3. Increasing awareness and adoption of point-of-care testing
3.2.2. Market restraint analysis
3.2.2.1. Challenges related to sample integrity and storage
3.2.2.2. High initial setup costs and infrastructure requirements
3.3. Specimen Collection Cards Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Specimen Collection Cards Market: Type of Specimen Estimates & Trend Analysis
4.1. Type of Specimen Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Specimen Collection Cards Market by Type of Specimen Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Blood
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
4.4.2. Saliva
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Urine
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Buccal cells
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Specimen Collection Cards Market: Material Estimates & Trend Analysis
5.1. Material Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Specimen Collection Cards Market by Material Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Cotton & Cellulose-based
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Fiber-based
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Others
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Specimen Collection Cards Market: Product Estimates & Trend Analysis
6.1. Product Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Specimen Collection Cards Market by Product Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Whatman 903
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Ahlstrom 226
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. FTA
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Specimen Collection Cards Market: Application Estimates & Trend Analysis
7.1. Application Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global Specimen Collection Cards Market by Application Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. New Born Screening (NBS)
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. Infectious Diseases Testing
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Therapeutic Drug Monitoring
7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Forensics
7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Research
7.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Wellbeing/Health Monitoring
7.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Others
7.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Specimen Collection Cards Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Market Share, 2024 & 2030
8.2. Segment Dashboard
8.3. Global Specimen Collection Cards Market by Distribution Channel Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Online
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.4.2. Offline
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Specimen Collection Cards Market: End Use Estimates & Trend Analysis
9.1. End Use Market Share, 2024 & 2030
9.2. Segment Dashboard
9.3. Global Specimen Collection Cards Market by End Use Outlook
9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.4.1. Hospitals & Clinics
9.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
9.4.2. Diagnostic Laboratories
9.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. Others
9.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Specimen Collection Cards Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2024 & 2030
10.2. Regional Market Dashboard
10.3. Global Regional Market Snapshot
10.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
10.5. North America
10.5.1. U.S.
10.5.1.1. Key country dynamics
10.5.1.2. Regulatory framework/ reimbursement structure
10.5.1.3. Competitive scenario
10.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
10.5.2. Canada
10.5.2.1. Key country dynamics
10.5.2.2. Regulatory framework/ reimbursement structure
10.5.2.3. Competitive scenario
10.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
10.5.3. Mexico
10.5.3.1. Key country dynamics
10.5.3.2. Regulatory framework/ reimbursement structure
10.5.3.3. Competitive scenario
10.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
10.6. Europe
10.6.1. UK
10.6.1.1. Key country dynamics
10.6.1.2. Regulatory framework/ reimbursement structure
10.6.1.3. Competitive scenario
10.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
10.6.2. Germany
10.6.2.1. Key country dynamics
10.6.2.2. Regulatory framework/ reimbursement structure
10.6.2.3. Competitive scenario
10.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
10.6.3. France
10.6.3.1. Key country dynamics
10.6.3.2. Regulatory framework/ reimbursement structure
10.6.3.3. Competitive scenario
10.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
10.6.4. Italy
10.6.4.1. Key country dynamics
10.6.4.2. Regulatory framework/ reimbursement structure
10.6.4.3. Competitive scenario
10.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
10.6.5. Spain
10.6.5.1. Key country dynamics
10.6.5.2. Regulatory framework/ reimbursement structure
10.6.5.3. Competitive scenario
10.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
10.6.6. Norway
10.6.6.1. Key country dynamics
10.6.6.2. Regulatory framework/ reimbursement structure
10.6.6.3. Competitive scenario
10.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
10.6.7. Sweden
10.6.7.1. Key country dynamics
10.6.7.2. Regulatory framework/ reimbursement structure
10.6.7.3. Competitive scenario
10.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
10.6.8. Denmark
10.6.8.1. Key country dynamics
10.6.8.2. Regulatory framework/ reimbursement structure
10.6.8.3. Competitive scenario
10.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
10.7. Asia Pacific
10.7.1. Japan
10.7.1.1. Key country dynamics
10.7.1.2. Regulatory framework/ reimbursement structure
10.7.1.3. Competitive scenario
10.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
10.7.2. China
10.7.2.1. Key country dynamics
10.7.2.2. Regulatory framework/ reimbursement structure
10.7.2.3. Competitive scenario
10.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
10.7.3. India
10.7.3.1. Key country dynamics
10.7.3.2. Regulatory framework/ reimbursement structure
10.7.3.3. Competitive scenario
10.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
10.7.4. Australia
10.7.4.1. Key country dynamics
10.7.4.2. Regulatory framework/ reimbursement structure
10.7.4.3. Competitive scenario
10.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
10.7.5. South Korea
10.7.5.1. Key country dynamics
10.7.5.2. Regulatory framework/ reimbursement structure
10.7.5.3. Competitive scenario
10.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
10.7.6. Thailand
10.7.6.1. Key country dynamics
10.7.6.2. Regulatory framework/ reimbursement structure
10.7.6.3. Competitive scenario
10.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
10.8. Latin America
10.8.1. Brazil
10.8.1.1. Key country dynamics
10.8.1.2. Regulatory framework/ reimbursement structure
10.8.1.3. Competitive scenario
10.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
10.8.2. Argentina
10.8.2.1. Key country dynamics
10.8.2.2. Regulatory framework/ reimbursement structure
10.8.2.3. Competitive scenario
10.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
10.9. MEA
10.9.1. South Africa
10.9.1.1. Key country dynamics
10.9.1.2. Regulatory framework/ reimbursement structure
10.9.1.3. Competitive scenario
10.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
10.9.2. Saudi Arabia
10.9.2.1. Key country dynamics
10.9.2.2. Regulatory framework/ reimbursement structure
10.9.2.3. Competitive scenario
10.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
10.9.3. UAE
10.9.3.1. Key country dynamics
10.9.3.2. Regulatory framework/ reimbursement structure
10.9.3.3. Competitive scenario
10.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
10.9.4. Kuwait
10.9.4.1. Key country dynamics
10.9.4.2. Regulatory framework/ reimbursement structure
10.9.4.3. Competitive scenario
10.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Recent Developments & Impact Analysis, By Key Market Participants
11.2. Company/Competition Categorization
11.3. Vendor Landscape
11.3.1. Key company market share analysis, 2024
11.3.2. QIAGEN
11.3.2.1. Company overview
11.3.2.2. Financial performance
11.3.2.3. Product benchmarking
11.3.2.4. Strategic initiatives
11.3.3. PerkinElmer, Inc
11.3.3.1. Company overview
11.3.3.2. Financial performance
11.3.3.3. Product benchmarking
11.3.3.4. Strategic initiatives
11.3.4. DBS System SA
11.3.4.1. Company overview
11.3.4.2. Financial performance
11.3.4.3. Product benchmarking
11.3.4.4. Strategic initiatives
11.3.5. Danaher Corporation
11.3.5.1. Company overview
11.3.5.2. Financial performance
11.3.5.3. Product benchmarking
11.3.5.4. Strategic initiatives
11.3.6. Eastern Business Forms, Inc
11.3.6.1. Company overview
11.3.6.2. Financial performance
11.3.6.3. Product benchmarking
11.3.6.4. Strategic initiatives
11.3.7. Ahlstrom
11.3.7.1. Company overview
11.3.7.2. Financial performance
11.3.7.3. Product benchmarking
11.3.7.4. Strategic initiatives
11.3.8. ARCHIMED Life Science GmbH
11.3.8.1. Company overview
11.3.8.2. Financial performance
11.3.8.3. Product benchmarking
11.3.8.4. Strategic initiatives
11.3.9. GenTegra LLC
11.3.9.1. Company overview
11.3.9.2. Financial performance
11.3.9.3. Product benchmarking
11.3.9.4. Strategic initiatives
11.3.10. FortiusBio
11.3.10.1. Company overview
11.3.10.2. Financial performance
11.3.10.3. Product benchmarking
11.3.10.4. Strategic initiatives
11.3.11. CENTOGENE N.V.
11.3.11.1. Company overview
11.3.11.2. Financial performance
11.3.11.3. Product benchmarking
11.3.11.4. Strategic initiatives